Publications

Wikoff D, DeVito M, Walker N, Hixon G, Harris M, Tachovsky A, Birnbaum L, Haws L. Application of machine learning in the development of a weighting framework for evaluating estimates of relative potency for dioxin-like compounds. Presented at Society of Toxicology 51st Annual Meeting, San Francisco, CA, March 2012.

Lynch M, Brown L, Chun A, Reid J, Russel P. Risk communication for the Toxic Release Inventory. Poster presentation to Society for Risk Analysis, 2012.

O’Brien TJ, Hao D, Suh M, Proctor D, Thompson CM, Harris MA, Parsons BL, Meyers MB. 2012. K-ras codon 12 GGT to GAT mutation is not elevated in the duodenum of mice subchronically exposed to hexavalent chromium in drinking water. Presented at the Society of Toxicology’s 51st Annual Meeting, March 11-15, San Francisco, CA.

Thompson C, Perry C, Gaylor D, Tachovsky A, Burkhalter B, Haws L. Derivation of an oral reference dose and drinking water screening level for sulfolane using benchmark dose modeling. Presented at Society of Toxicology 50th Annual Meeting, Washington DC, March 2011.

Mitchell M, Taylor A, Lowe K, Langeberg W, et al. Prevalence of bone metastasis in breast cancer patients and subsequent survival: A systematic and quantitative review of the literature. Presented at the San Antonio Breast Cancer Symposium, San Antonio, TX, December 2011.

Mitchell M, Taylor A, Lowe K, Langeberg W, Alexander D, Kelsh M, et al. Breast cancer bone metastasis prevalence and survival outcomes: A quantitative review of the literature. Presented at the 34th Annual San Antonio Breast Cancer Symposium, San Antonio, TX, December 6–10, 2011.

Sterner T, Ruark C, Covington T, Gearhart J. Monte Carlo and sensitivity analyses of a PBPK model for the oxime TMB-4. Poster presented at the Chemical and Biological Defense Science and Technology Conference, Las Vegas, NV, November 2011.

Jensen I, Helm T, Cyr P. Impact of dysphagia on U.S. hospital charges in patients with comorbid conditions. Abstract PGI9, ISPOR 14th Annual European Congress, 2011.

Jensen I, Helm T, Cyr P. Impact of complications from dysphagia on hospital charges in the United States. Abstract PGI7, ISPOR 14th Annual European Congress, 2011.

Oller A, Henderson RG. Bioaccessibility testing and its application to read-across for hazard assessment and risk characterisation of metals. Annual Meeting of the Belgian Society for Toxicology and Ecotoxicology (BelTox), 2011.

Robison TW. Toxicology in the nonclinical development of drugs and biologics. Pharmaceutical Education and Research Institute, Genetic Toxicology, Arlington, VA, October 2011.

Vivanco S. IVAN’s effectiveness in identifying and addressing environmental harms in underserved communities. University of California, Los Angeles Fielding School of Public Health Graduate Seminar, Los Angeles, CA, Fall 2011.

Mitchell M, Taylor A, Lowe K, Langeberg W, et al. Prevalence of bone metastases among breast, lung, and prostate cancer patients. Presented at the 27th International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Chicago, IL, August 2011.

Jiang X, Knutson K, Zwica L, Lee S-Y, Chen Q, Hong B, Zhong X, Hao W, et al. The University of Michigan Dioxin Exposure Study: Predictors of household dust PCDD, PCDF, and PCB concentrations. Presented at the 32nd International Symposium on Halogenated Persistent Organic Pollutants – Dioxin 2011, Brussels, Belgium, August 2011.

Jiang X, Zwica L, Knutson K, Towey T, Hedgeman E, Franzblau A, Chen Q, Lee S-Y, et al. Measurements of household dust concentrations of PCDDs, PCDFs, and PCBs from a community in Michigan, USA. Presented at the 32nd International Symposium on Halogenated Persistent Organic Pollutants – Dioxin 2011, Brussels, Belgium, August 2011.

Diliberto JJ, Sirinek L, Burkhalter B, Wikoff DS, Hixon G, Becker J, Patterson DG, Turner W, Tachovsky JA, Birnbaum LS, Haws LC. Endometriosis in a cohort of women living in the Kanawha River Valley in West Virginia: Blood levels of non-dioxin-like PCBs and relationship with BMI and age. Presented at Dioxin 2011, Brussels, Belgium, August 2011.

Haws LC, DeVito MJ, Walker NJ,Harris MA, Tachovsky JA, Birnbaum LS, Farland WH, Wikoff DS. Development of a consensus-based weighting framework for evaluating estimates of relative potency for dioxin-like compounds that includes consideration of data from human cells. Presented at Dioxin 2011, Brussels, Belgium, August 2011.

Haws LC, Fitzgerald L, Burkhalter B, Harris M, Wikoff DS. Assessment of the US EPA’s proposed toxicological values for TCDD for regulation of dioxin-like compounds in foods: Bridging the science divide in a global market. Presented at Dioxin 2011, Brussels, Belgium, August 2011.

Thomas RS, Rowlands JC, Budinsky RA, Thompson CM, Urban JD, Dombkowski, A. 2011. Genomic approaches for relative potency assessment. Presented at Dioxin 2011, Brussels, Belgium, August 2011.

Wikoff DS, Thompson C, Walker N, DeVito M, Harris M, Birnbaum L, Haws L. Derivation of relative potency estimates using benchmark dose modeling: A case study with TCDF. Presented at Dioxin 2011, Brussels, Belgium, August 2011.